Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

239 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.
Bonora E, Muggeo M. Bonora E, et al. Among authors: muggeo m. Diabetologia. 2001 Dec;44(12):2107-14. doi: 10.1007/s001250100020. Diabetologia. 2001. PMID: 11793012 Review.
Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study.
Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, Zenti MG, Branzi P, Santi L, Muggeo M. Bonora E, et al. Among authors: muggeo m. Eur J Clin Invest. 1997 Mar;27(3):248-54. doi: 10.1046/j.1365-2362.1997.1060658.x. Eur J Clin Invest. 1997. PMID: 9088862
Plasma C-peptide response to oral glucose load in hyperthyroidism.
Bonora E, Manicardi V, Zenere M, Moghetti P, Coscelli C, Muggeo M. Bonora E, et al. Among authors: muggeo m. J Endocrinol Invest. 1990 Jul-Aug;13(7):555-8. doi: 10.1007/BF03348624. J Endocrinol Invest. 1990. PMID: 2229928 Clinical Trial.
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
Del Prato S, Nosadini R, Tiengo A, Tessari P, Avogaro A, Trevisan R, Valerio A, Muggeo M, Cobelli C, Toffolo G. Del Prato S, et al. Among authors: muggeo m. J Clin Endocrinol Metab. 1983 Nov;57(5):904-10. doi: 10.1210/jcem-57-5-904. J Clin Endocrinol Metab. 1983. PMID: 6352727
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.
Kumar S, Boulton AJ, Beck-Nielsen H, Berthezene F, Muggeo M, Persson B, Spinas GA, Donoghue S, Lettis S, Stewart-Long P. Kumar S, et al. Among authors: muggeo m. Diabetologia. 1996 Jun;39(6):701-9. doi: 10.1007/BF00418542. Diabetologia. 1996. PMID: 8781766 Clinical Trial.
Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance.
Bonora E, Tessari R, Micciolo R, Zenere M, Targher G, Padovani R, Falezza G, Muggeo M. Bonora E, et al. Among authors: muggeo m. Diabetes Care. 1997 Apr;20(4):627-31. doi: 10.2337/diacare.20.4.627. Diabetes Care. 1997. PMID: 9096992
Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study.
Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck Study. Bonora E, et al. Among authors: muggeo m. Int J Obes Relat Metab Disord. 2003 Oct;27(10):1283-9. doi: 10.1038/sj.ijo.0802381. Int J Obes Relat Metab Disord. 2003. PMID: 14513078
Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, Verlato G. Muggeo M, et al. Diabetes Care. 2000 Jan;23(1):45-50. doi: 10.2337/diacare.23.1.45. Diabetes Care. 2000. PMID: 10857967
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young Type 1 diabetic individuals.
Zoppini G, Targher G, Trombetta M, Lippi G, Muggeo M. Zoppini G, et al. Among authors: muggeo m. Diabet Med. 2008 Nov;25(11):1283-8. doi: 10.1111/j.1464-5491.2008.02575.x. Diabet Med. 2008. PMID: 19046217
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, Muggeo M, Arcaro G. Targher G, et al. Among authors: muggeo m. Diabet Med. 2008 Jan;25(1):45-50. doi: 10.1111/j.1464-5491.2007.02327.x. Diabet Med. 2008. PMID: 18199131
239 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page